Sep 03, 2019

Starpharma’s VivaGel® BV regulatory approvals continue in Asia

Starpharma’s VivaGel® BV regulatory approvals continue in Asia

Finance News Network reported Starpharma received further regulatory approval in another Asian country for its breakthrough product for bacterial vaginosis, VivaGel® BV. The news follows the first approval in the region announced on 15 August.

Read the full news coverage here.

 This contains certain forward-looking statements.